After the final POC, optimism spikes


After the final POC, optimism spikes. That is when many deals die.

The AE feels confident. The SE feels validated. The champion says, “This is exactly what we need.”

The pipeline call sounds good.

That is the problem.

Because optimism is not evidence.

And late-stage emotion hides late-stage risk.

So we grade the deal.

Not the last call. The full record.

Every transcript. Every follow-up email. Every side thread that never made it into the CRM.

Then we score it.

Green. Yellow. Red.

Evidence only.

If it was not said. If it was not written. It is Red.

No assumptions. No “they’re aligned.” No “they love it.” No forecasting hope.

The healthcare POC in the image looks strong at first glance.

Operational drag confirmed. Compliance exposure discussed. Technical criteria met. Board priority referenced.

On the call, it sounds close.

Then we grade it.

Economic Buyer: Red. “CFO is supportive” but has not joined a single meeting.

Procurement: Yellow. “Looping them in soon.”

Paper process: Yellow. “Legal will need to review.”

Champion: Yellow. Strong advocate. No budget authority.

That is not a strong deal.

That is a technically validated project with executive risk.

Strong pain does not replace buying authority. Clear criteria does not secure budget. A successful POC does not equal approval.

When Economic Buyer is Red, this is what actually happens:

It sits in commit. It slips at the end of the quarter. You burn SE cycles on follow-ups. You explain variance to senior leadership. You carry false confidence into next month.

And no one admits the real issue was forecast discipline.

Late-stage deals should feel boring.

The buyer knows the metrics. The budget is confirmed. The paper process is mapped. The executive has shown up.

If it still feels emotional, something is unproven.

Before you move your next POC into commit, ask:

What is Red that we are pretending is Yellow?

That answer determines your quarter.

♻️ Repost to help someone in your network 🔔 Follow Barry Flanagan for daily AI + Tech Sales insights


View original post on LinkedIn →